Guangzhou Chuanger Biotechnology Co., Ltd. recently announced that in order to meet the needs of the company's business development and overseas market layout, the company plans to set up a wholly-owned subsidiary in Hong Kong, the investment amount is not more than 2,000 RMB ten thousand Yuan.

Ring view:Guangzhou Chuanger Biotechnology Co., Ltd. is a high-tech enterprise that has mastered the key technologies of biomedical active collagen materials, and is deeply engaged in the fields of active collagen raw materials, medical devices and biological skin care products, integrating R&D, production and sales. The purpose of this overseas investment is to expand the company's business in overseas markets and promote the company's internationalization process. The company intends to make full use of Hong Kong's geographical advantages as an important international financial center and trade center in the world and long-term connection with the international market, so as to carry out the communication and cooperation between the company and the international market and form the linkage of domestic and foreign business. The establishment of the Hong Kong subsidiary will meet the needs of the company's business development and overseas market layout in the future.

CycloseThe company focuses on providing corporate audit, tax declaration, registration, annual inspection, tax planning and other services in Hong Kong, Singapore, Dubai and other regions. Efficient, rigorous, intimate service has been favored by many private enterprises, listed companies and large state-owned enterprises.